Mucinex D Sinus-Max Tablets from Canada
Extended-release tablets combining pseudoephedrine HCl with guaifenesin for expectorant and decongestant effects in sinus congestion relief. Classified in HTS 3004.42.00.00 for containing pseudoephedrine salts in retail measured doses as mixed medicaments for therapeutic use.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Monitor for FDA import alert 75-09 on pseudoephedrine; provide sales records if requested
• Confirm exact mg dosage per tablet matches labeling for measured dose classification